ABSTRACT Background: Recurrent aphthous stomatitis (RAS) is a common chronic inflammation affecting oral mucosa that lead to mucosal ulceration. The causes are unclear, but dysregulation of the immune response has been proposed to be implicated in the development of the disease. In this study, we hypothesized that RAS is provoked by the dysregulation of the complement system, through the impairment of the function of complement regulatory proteins, the present study has aimed to investigate the impact of CFH gene SNPs that encodes the production of complement factor H in RAS development. Subject and Methods: Blood samples from 46 patientswith recurrent aphthus stomatitis were collected including 35 males and 11 females and 46 age and sex matched apparently healthy (with healthy oral cavity) volunteersincluding 23 males and 23 females were involved as a control group. Gnomic DNA was extractedfrom each blood sampleusing the isopropanol/ethanol method. Specific primers were used to amplify the CFH gene fragment that harbors the rs1061170 site encoding theTyr402 aminoacid. The PCR products were digested with NlaIII restriction enzyme. Results: A significant difference was found between the age groups among the RAS patients in regard to the severity of and recurrence of the RAS episodes, it was found to be higher significantly among the age group (20-30 years) compared to other age groups among RAS patients. Out of the 46 RAS patients, the CFH single nucleotide polymorphism (SNP), Tyr402His polymorphism variant was detected in 18 (39.1%); 11 (23.9%) females and 7 (15.2%) males, represented as 8 (17.4%) Tyr/His heterozygous variants and 10 (21.7%) were His/His homozygous variant. Among the 46 healthy control group, the CFH single nucleotide polymorphism (SNP), (Tyr402His polymorphism variant) was detected in 6 (13%) all of them were Tyr402His variant, 2 (4.3%) males and 4 (8.7%) females. There was a significant difference in the CFH (Tyr/His, His/His) variants rates between the RAS group and the healthy control group (p <0.05), but there was no significant difference of CFH (Tyr/His, His/His) variants rates between the males and females in the RAS group. Conclusions: We suggest that Tyr402Hispolymorphism can be considered as a risk factor for the RAS development, and His204His variant is more associated with the disease, however, more studies are recommended to be conducted on a larger sample size to confirm these evidences.
ecurrent aphthous stomatitis (RAS) is regarded as the most common ulcerative disease of the oral mucosa associated with painful rounded ulcers of erythematous margin and yellowish-gray pseudomembranous center. Also it occurs in otherwise healthy individuals and is typically located on the buccal and labial mucosa and tongue 1 . Diseases which also cause oral ulcers that may be mistaken for RAS include Behçet's disease, cyclic neutropenia, recurring intraoral herpes infections, HIV-related oral ulcers or gastrointestinal diseases such as Crohn's disease and ulcerative colitis 2 . About 20%
of the population undergo episodes of RAS, and the evidence which depends on the ethnic and socioeconomic status ranges between 5% to 50%, such is based on the nature of the examined populations as well as on the methodology and design of the study 3 .The second life decade (10-19 years of age) is regarded as the period in which the RAS occurrence peaks and the first episode starts in childhood. However, when the RAS begins or elevate in severity significantly during the third decade of age, the etiology of the episode might be attributed to an underlying disease or syndrome likehematologic, immunologic, connective tissue autoimmune disease, or even Behçet's syndrome 4 .The etiologic factors of RAS ulcer are not well known and need to more explored, several factors are proposed to be implicated, many of them are local or systemic, like immunologic, hereditary, nutritional, and infectious agents in addition to some medications particularly the immunosuppressive drugs 5, 6 .As a predisposing etiologic factor, the abnormality in the immune response has taken a significant space in researching. It has been suggested that there are many immune-mediated responsesrelated to the development of RAS, including T lymphocytescytotoxicitytoward the oral epithelium, antibody-dependent cellmediated cytotoxicity, and defects indifferent lymphocyte subpopulations 7 .
One of the theories is that the damage might be induced by the deposition of immune complexes within the oral epithelium 8 . Immunologic response towards specific antigens of the oral mucosa has been found to provoke the aphthous stomatitis development 9 . The response takes place as a result of not proper initiation of cytokine cascade, that initiate othercertain immune mechanisms 9,10 . Furthermore, other reports haveemphasized on the role of the autoimmunity in developing the disease 11 .
Factor H is regarded as one of the members of the complement system activation regulatory family which plays as a control protein of the complement system. It is a large (155 kilodaltons), soluble glycoprotein that circulates in human plasma, and found to regulate the complement system that has been activated through the alternative pathway, which ensures that the complement system does not cause the damage to the host tissues and only directed against the pathogens. Factor H protein controls the complement system activation on the surface of the host cells through the activity of cleavage C3b by cofactor Factor, and decay accelerating activity towards the alternative pathway C3-convertase C3bBb. The protection activity of factor H is exerted on host cells and surfaces but not on the surfaces of pathogens, because it binds to glycosaminoglycans (GAGs) which are normallyintegrated into thesecells' membranes but not the pathogen surfaces 12 .
Aberrant factor H activity has been implicated in clinical manifestations 13, 14 .
Reduction in complement activity on pathogenic cells is due to overactive factor H leading to the increase in susceptibility to infections. Improper activity of factor H might leads to increased complement activity that develops autoimmune diseases. Therefore, it is expected that mutations andgeneticpolymorphisms in factor H probably result in pathologic conditions 15, 16 . Furthermore, a single nucleotide polymorphism (SNP), Tyr402His, located in exon 9 of the CFH gene and representing a tyrosine to histidine change at amino acid position 402 in the CFH protein that alters the complement activity 17, 18 . We hypothesized that RAS is provoked by the dysregulation of the complement system, through the impairment of the function of regulatory complement protein; we aimed at investigating the potential impact of CFH gene SNPs as a risk factor of RAS.
MATERIAL AND METHODS
This case-control study has been conducted at Duhok medical research center (DMRC). The study population composed of 46 patients with RASincluding 35 males and 11 females and 46 apparently healthy individuals (including 23 males and 23 females)were involved as a control group. The study has been approved by the local ethical committee of the directorate of health at Duhok city, consent was provided by each participant. The oral clinical examination has been conducted by qualified oral medicine dentist, the medical history of patients was registered through a questionnaire. The RAS clinical picture was used for the diagnosis during the examination. The number of aphthae per flare-up and the frequency of recurrence was used to determine the severity of the disease (3 or less than 3; more than 3) as reported by the patients. The patients that have experienced a minimum of three episodes of RAS within past one year are included. Patients, under medication that could be associated with oral ulcers or H. pylori (such as antibiotics, proton pump inhibitors, H2 receptor blockers, Bismuth derivatives, non-steroidal antiinflammatory drugs, chemotherapeutic agents, or vitamin supplements) for one month prior to the study, were excluded. Women during pregnancy and menstruation were excluded as well. Five milliliters of the venous blood has been collected from each subject, For CFH gene polymorphism, genomic DNA was extracted from peripheral blood collected withEDTA-anticoagulant by isopropanol method as described by 19 . The concentration of DNA was measured by Nano Drop spectrophotometer (Thermo Fisher). DNA was amplified using polymerase chain reaction (PCR) which was carried out on thermal cycler (Applied Biosystems, USA).
PCR-restriction fragment length polymorphism (PCR-RFLP) was used for the genotyping of CFH as presented by Nada et al (2015) , with minor modification and optimization 20 . Briefly the primer pair of
CFH-F (5′-ACT GTG GTCTGC GCT TTT G-3′) and CFH-R (5′-TTT TTG GAT
GTT TATGCA ATC TT-3′) was used to amplify the 244-bp DNA fragment that includes the (rs1061170) variant site. The PCR was performed in a 25 μl reaction mixture containing 200 ng genomic DNA, 12.5 μl master mix using Hot-Star-Taq Green DNA Polymerase (250 units), 5 ρmol each forward and reverse primers.
The thermal cycles were: initial denaturation of 94ºC for 5 minutes; 35 cycles of 94ºC for 30 seconds; 62ºC for 30 seconds; 72ºC for 35 seconds; and a final extension at 72ºC for 5 minutes. The 244-bp PCR fragments were digested by NlaIII restriction enzyme (Thermo Scientific) at 37ºC for 2-4 hours. The digested fragments have been separated and visualized on 2% agarose gel in a UV illumination chamber.
STATISTICAL ANALYSIS
The statistical package for the social sciences (SPSS) was used in the data analyses. The difference of CFH genotypes distribution was tested by Chi Square test. The CFH genotype association with the risk of RAS was estimated by odds ratio (OR) and 95% confidence interval (95% CI). P value (< 0.05) was regarded significant.
RESULTS
In the present study; 92 individuals were enrolled and divided in to two groups: the first group was the study group which composed of 46 patients with RAS disease, consisting of 11 females (23.91%) and 35 males (76.08%), their age range was (15-40 years), the family history of RAS disease was positive for 24 patients (52.17%). The second group was the control group which composed of 46 apparently healthy individuals, consisting of 23 females (50%) and 23 males (50%), their age range was (15-30 years), only one individual (2.173%) had had a family history of RAS disease. Among the RAS patients, the male rate was significantly higher compared to females (p < 0.05). A significant difference was found between the age groups among the RAS patients in regard to the severity of and recurrence of the RAS episodes, it was found to be higher significantly among the age group (20-30 years) compared to other age groups among RAS patients (p < 0.001). Based on information provided by the subjects involved in the study, the attack frequency of RAS per month was 1 -4. Using primers specifically targeting the CFH gene flanking the 402 Tyr region, the PCR gave a DNA band of 244-bp. 24 .In the current study, we found that the rate of the RAS is significantly higher among males (76.08%) compared to females (23.91%), these results are in contrast to those reported by 25 , they found that females (56.3%) were more frequently affected than males (43.7%) and this difference was statistically significant (p<0.005). Also the results in the current study were inconsistent results with the findings of Safadi 26 . However, the immune response of the females is more affected by the emotional situations and stress, and the hormonal changes in pregnancy and menstruation plays a significant role in altering the immune response and RAS episodes 27 . The controversy of RAS findings in the present study compared to others regarding the gender frequency might be due to the smaller sample size recruited in the current study that could not be a real representative of the population. Our study showed a significant difference between the age groups among the RAS patients in regard to the severity of and recurrence of the RAS episodes, it was found to be higher significantly among the age group (20-30 years) compared to other age groups among RAS patients (p < 0.001), denoting that the second decade of age is associated with higher risk of RAS. These results are in accordance with the findings of Davatchiet al., (2008) in Iran 28 , and Mustafa J. Abdullah (2013) in Sulaimani, Iraq 29 , they indicated that the most commonly affected age group was 20-29 years and the prevalence decreased with aging. It has been assumed that the occupation status and the education might have a significant impact on the prevalence of RAS, as the educational and occupational level elevates the opportunity of getting the stress and anxiety increases as well, that's what is clearly observed during the students' exams. The complement system consists of a cascade of effective proteins leading to cell lysis 30 .
Digesting the PCR products with
Complement factor H (CFH) is crucial regulator in the complement system activation through the alternative pathway. Its' biological role is to inhibit the complement pathway response by binding to C3b and damaging the C3 convertase 31, 32 .
To the best of our knowledge, this is the first study to explore the CFH SNPs as a risk factor for the RAS. In the present study, we explored the impact of CFH Tyr402His single nucleotide polymorphism on the prevalence of RAS. We found that CFH Tyr402His polymorphism is significantly associated with RAS compared to healthy individuals (p<0.05), but there was no significant difference between the males and females among the RAS group. However, no data are published about the impact of the CFH Tyr402His single nucleotide polymorphism on RAS development, but the link between the CFH Tyr402His variants and other diseases has been reported. Klein et al has found a strong link between a single amino acid variant in the (Tyr402His) of complement factor H and age-related macular degeneration (ARMD) 33 . It has been found the Dense deposit disease (membranoproliferative glomerulonephritis. type II) has a massive complement response through the alternative pathway in an uncontrolled process and impairment in controlling surface activation 34 . It has been assumed that CFH Tyr402His mutant has led to the reduction CFH affinity for Creactive protein (CRP), which in turn might be involved the modulation of the alternative pathway complement response and effect via CFH binding 35 , that's might leads to the continuous activation of the immune response of the oral mucosal layer, resulting in defects in the regulation of the alternative pathway of the complement response, recurrent and exaggerated inflammation, and oral mucosal damage because of the accumulation of the membrane attack complex (MAC) on the mucosal cell membranes 36 .The results represented in the current study reveal a 3.82 fold increased risk of RAS in Tyr204His, His204His variants, but the strongest association was found between His204His variant carrier. In a study conducted by Sijia Cao et al., 2016, they declared that CFH Y402H polymorphism is a known genetic risk factor of age-related macular degeneration (AMD). The contribution to the disease process may be through increased activation of the NF-κB pathways and upregulation of inflammasome genes. So in the case of RAS, the NF-κB pathway is expected to mediate the expression of proinflammatory mediators, including inflammasome products, thereby contribute to the local proinflammatory responses in the oral mucosa surfaces 37 .
Based on the evidences obtained in this study, we suggest that Tyr402His polymorphic can be considered as a risk factor for the RAS development, and His402His variant is more associated with the disease, however, more studies are recommended to be conducted on a larger sample size to confirm these evidences. 
